Trials / Conditions / Hypercholesterolemia, Familial

Hypercholesterolemia, Familial

27 registered clinical trials studyying Hypercholesterolemia, Familial — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Screening for Familial Hypercholesterolemia in Children NCT06555120	Centre Hospitalier Universitaire, Amiens	N/A
Recruiting	PET Imaging of Inflammation and Lipid Lowering Study NCT04073797	University of Cambridge	N/A
Recruiting	Clinical Decision Support for Familial Hypercholesterolemia NCT03989167	University Hospital, Linkoeping	N/A
Unknown	Diet Quality and Coronary Artery Calcification in Adults With Heterozygous Familial Hypercholesterolemia NCT04837638	Laval University	—
Active Not Recruiting	Genetic Testing and Motivational Counseling for FH NCT04656028	National Medical Research Center for Therapy and Preventive Medicine	N/A
Completed	Evaluating the Efficacy of Pediatric Lipid Screening Alerts NCT04118348	Geisinger Clinic	N/A
Completed	Expression of Pro- and Anti-inflammatory Cytokines During Anti-PCSK9 in Familial Hypercholesterolemia NCT06231459	Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado	Phase 4
Completed	Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System D NCT03795038	Fresenius Medical Care Deutschland GmbH	N/A
Unknown	Subclinical Atherosclerosis in Patients With Familial Hypercholesterolemia Treated With Evolocumab® NCT04313270	Federico II University	—
Completed	Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry NCT03110432	GWT-TUD GmbH	—
Completed	Regeneron 1331 Kinetics Sub-Study HoFH NCT04722068	University of Pennsylvania	N/A
Completed	Screening Protocol for a Gene Therapy Trial in Subjects With Homozygous Familial Hypercholesterolemia NCT03018678	University of Pennsylvania	—
Completed	Is Family Screening Improved by Genetic Testing of Familial Hypercholesterolemia NCT04526457	University of Pennsylvania	N/A
Terminated	A Study of Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterol NCT01583647	Merck Sharp & Dohme LLC	Phase 1
Completed	Safety and Efficacy of the DALI LDL-adsorber and MONET Lipoprotein Filter NCT01753232	Fresenius Medical Care Deutschland GmbH	—
Completed	Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Particip NCT01524289	Merck Sharp & Dohme LLC	Phase 3
Completed	Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hyperc NCT01375751	Amgen	Phase 2
Completed	Bone Marrow Stem Cells as a Source of Allogenic Hepatocyte Transplantation in Homozygous Familial Hypercholest NCT00515307	University of Tehran	Phase 1
Terminated	Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED) NCT00384293	Merck Sharp & Dohme LLC	Phase 3
Completed	Study of ISIS 301012 (Mipomersen) in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering The NCT00281008	Kastle Therapeutics, LLC	Phase 2
Completed	Dose-escalating Safety Study of ISIS 301012 in Homozygous Familial Hypercholesterolemia Subjects on Lipid Lowe NCT00280995	Kastle Therapeutics, LLC	Phase 2
Completed	Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder NCT00134511	Pfizer	Phase 3
Completed	Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerole NCT00134485	Pfizer	Phase 3
Completed	Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvasta NCT00136981	Pfizer	Phase 3
Terminated	Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPL NCT00092833	Organon and Co	Phase 3
Completed	Hyperapo B and Coronary Heart Disease NCT00005168	National Heart, Lung, and Blood Institute (NHLBI)	—
Completed	NHLBI Type II Coronary Intervention Study NCT00000594	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3